Status:
ENROLLING_BY_INVITATION
The Role and Mechanism of GPER-Hippo-CBS/H2S Pathway in Preeclampsia
Lead Sponsor:
Hao Feng
Conditions:
Preeclampsia
Eligibility:
FEMALE
Up to 40 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn about in health conditions. The main questions it aims to answer are: * The pathological significance of GPER in uterine artery dilation in preeclampsia * ...
Detailed Description
1. Measure the content of H2S in uterine arterial smooth muscle and circulation of normal pregnancy and PE pregnant women, and analyze the relationship between the content of H2S in uterine arterial s...
Eligibility Criteria
Inclusion
- Full term pregnancy with clinical diagnosis of preeclampsia and normal pregnancy pregnant woman
- Pregnant women undergoing lower segment cesarean section for delivery
Exclusion
- Combined with chronic hypertension, kidney disease, intrahepatic cholestasis, etc Other basic diseases;
- Multiple pregnancy
- Pregnant women undergoing vaginal delivery
- Normal pregnant women who are\<37 weeks or\>40 weeks pregnant
Key Trial Info
Start Date :
April 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06205771
Start Date
April 10 2024
End Date
December 1 2029
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Shandong First Medical University &Shandong Provincial Qianfoshan Hospital
Jinan, Please Select, China, 250000